Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI—Indirect Proof of Principle on Its Pathogenicity

Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI—Indirect Proof of Principle on Its Pathogenicity

Here, we present the molecular diagnosis of a patient with a general clinical suspicion of Mucopolysaccharidosis, highlighting the different tools used to perform its molecular characterization. In order to decrease the turnaround time for the final report and contribute to reduce the “dia...

Full description

Bibliographic Details
Main Authors:	Maria Francisca Coutinho, Marisa Encarnação, Liliana Matos, Lisbeth Silva, Diogo Ribeiro, Juliana Inês Santos, Maria João Prata, Laura Vilarinho, Sandra Alves
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Diagnostics
Subjects:	mucopolysaccharidosis type vi (mps vi) lysosomal storage disorders (lsds) next-generation sequencing (ngs) splicing mutation functional studies
Online Access:	https://www.mdpi.com/2075-4418/10/2/58

Similar Items

Mutations in ARSB in MPS VI patients in India
by: Juby Mathew, et al.
Published: (2015-09-01)

Mutational analysis of ARSB gene in mucopolysaccharidosis type VI: identification of three novel mutations in Iranian patients
by: Nasrin Malekpour, et al.
Published: (2018-09-01)

Alder-Reilly Anomaly in Patients with Mucopolysaccharidosis VI
by: Taiane Alves Vieira, et al.
Published: (2008-09-01)

Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance
by: Mehmet Umut Akyol, et al.
Published: (2019-05-01)

Genetic Assessment of Mucopolysaccharidosis Type IV and the First Pathological Mutation of c.313A>G in the Iranian Population
by: Seyed Mehdi Shafaat, et al.
Published: (2020-03-01)

Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation
by: Rachel Sayuri Honjo, et al.
Published: (2020-02-01)

KHẢO SÁT CÁC ĐIỀU KIỆN THÍCH HỢP ĐỂ XÁC ĐỊNH CÁC VI NHỰA (MPs) TRONG MẪU CÁ
by: Tran Thi Ai My, et al.
Published: (2020-06-01)

Ocular features in mucopolysaccharidosis: diagnosis and treatment
by: Alessandra Del Longo, et al.
Published: (2018-11-01)

Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics
by: Abdellah Tebani, et al.
Published: (2019-01-01)

A Case Report of Mucopolysaccharidosis Type VI
by: SJ Hosseini, et al.
Published: (2018-12-01)

Assessing Lysosomal Disorders in the NGS Era: Identification of Novel Rare Variants
by: Marisa Encarnação, et al.
Published: (2020-09-01)

Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries
by: Villarreal M Solano, et al.
Published: (2021-09-01)

A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy
by: Francesca Furlan, et al.
Published: (2018-11-01)

Compound heterozygous missense mutations in a Chinese mucopolysaccharidosis type VI patient: a case report
by: Ming-Fang He, et al.
Published: (2021-05-01)

Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors
by: Rita Ferla, et al.
Published: (2021-03-01)

Mucopolysaccharidosis type VI on enzyme replacement therapy since infancy: Six years follow-up of four children
by: Dafne D.G. Horovitz, et al.
Published: (2015-12-01)

Design and Validation of a Custom NGS Panel Targeting a Set of Lysosomal Storage Diseases Candidate for NBS Applications
by: Valentina La Cognata, et al.
Published: (2021-09-01)

Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
by: Aneesh Karir, et al.
Published: (2018-06-01)

Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII – a European caregiver survey
by: Alexandra Morrison, et al.
Published: (2019-11-01)

Home treatment of type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) an alternative at this time of COVID‐19 pandemic: A case in Peru
by: Jenny Lucy Cortez Miranda, et al.
Published: (2020-12-01)

Mucopolissacaridose tipo VI (síndrome de Maroteaux-Lamy): avaliação da mobilidade articular e das forças de garra e de pinça Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength
by: Antonio Cardoso-Santos, et al.
Published: (2008-04-01)

Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS)
by: Karolina M. Stepien, et al.
Published: (2020-05-01)

The factors affecting lipid profile in adult patients with Mucopolysaccharidosis
by: Karolina M. Stepien, et al.
Published: (2017-09-01)

Pathogenesis of Mucopolysaccharidoses, an Update
by: Simona Fecarotta, et al.
Published: (2020-04-01)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
by: Valeria De Pasquale, et al.
Published: (2020-02-01)

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
by: Hsiang-Yu Lin, et al.
Published: (2016-06-01)

Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
by: J.A. Gilkes, et al.
Published: (2016-03-01)

Hip pathologies in mucopolysaccharidosis type III
by: Sandra Rafaela Breyer, et al.
Published: (2021-03-01)

The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis
by: Marta Moskot, et al.
Published: (2019-01-01)

Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory Diagnosis
by: Chih-Kuang Chuang, et al.
Published: (2021-08-01)

Biomarkers in Lysosomal Storage Diseases
by: Joaquin Bobillo Lobato, et al.
Published: (2016-12-01)

Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots
by: Anirudh J. Ullal, et al.
Published: (2014-01-01)

Growth Plate Pathology in the Mucopolysaccharidosis Type VI Rat Model—An Experimental and Computational Approach
by: Johana M. Guevara-Morales, et al.
Published: (2020-05-01)

Purification of human recombinant Naglu from Sf9 cells and uptake studies with MPS IIIB fibroblasts
by: Ashmead, Rhea
Published: (2019)

A model of mucopolysaccharidosis type IIIB in pigs
by: Qiang Yang, et al.
Published: (2018-10-01)

Terapia de reposição enzimática para as mucopolissacaridoses I, II e VI: recomendações de um grupo de especialistas brasileiros Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts
by: Roberto Giugliani, et al.
Published: (2010-01-01)

Synthesis of “<i>All-Cis”</i> Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
by: Maria Giulia Davighi, et al.
Published: (2020-10-01)

Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report
by: Erlane Marques Ribeiro, et al.
Published: (2014-01-01)

Silica-Based Nanoparticles for Protein Encapsulation and Delivery
by: Filippo Begarani, et al.
Published: (2018-11-01)

How Not to Miss the Mild Forms of Mucopolysaccharidosis Type I in Patients With Articular Manifestations of the Disease?
by: Natalia V. Buchinskaya, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_riv90ogkqse1t6l2uhqcb3v199